![Jörg Neermann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jörg Neermann
Directeur/Membre du Conseil chez
IMMUNIC, INC.
Fortune : 299 200 $ au 31/05/2026
Profil
Dr. Jörg Neermann is an Independent Non-Executive Director at Immunic, Inc. and a Chairman at Immunic AG.
He is on the Board of Directors at IDEA AG, Immunic, Inc., Affimed AG and Efficas Medical Foods & Nutrition LLC.
Dr. Neermann was previously employed as a Chief Executive Officer by Curexsys GmbH, a Non-Executive Director by ImCyse SA, a Non-Executive Director by ViCentra BV, a Non-Executive Director by Kuros Biosciences Ltd., a Non-Executive Director by EyeSense AG, a Non-Executive Director by Ventaleon GmbH, an Independent Non-Executive Director by Vivoryon Therapeutics NV, a Managing Partner by LSP Services Deutschland GmbH, a Non-Executive Director by NextGen Group Plc, a Partner by LSP Management Group BV, a Managing Partner by Deutsche Bank AG, a Managing Partner by DVC Deutsche Venture Capital, an Associate by Atlas Venture Advisors, Inc., a Chairman-Supervisory Board by 4SC AG, a Member-Supervisory Board by Affimed NV, a Member-Supervisory Board by Affimed NV Niederlassung Deutschland, a Director-Supervisory Board by Avontec GmbH, a Member-Supervisory Board by Curetis GmbH, a Vice Chairman-Supervisory Board by KeyNeurotek Pharmaceuticals AG, a Non-Executive Director by NextGen Sciences Ltd., a Director-Supervisory Board by Topotarget A/S, and a Director-Supervisory Board by Activaero GmbH.
He also served on the board at Vital Therapies, Inc., Kuros Biosurgery Holding AG, TopoTarget UK Ltd. and Vivendy Therapeutics Ltd. He received his undergraduate degree from Massachusetts Institute of Technology, an undergraduate degree from Technische Universität Braunschweig, an undergraduate degree from Harvard Business School and a doctorate degree from Technische Universität Braunschweig.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNIC, INC. 0,15 % | 26/05/2026 | 20 000 ( 0,15 % ) | 299 200 $ | 31/05/2026 |
Postes actifs de Jörg Neermann
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNIC, INC. | Directeur/Membre du Conseil | 01/04/2019 |
Affimed AG | Directeur/Membre du Conseil | - |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals in the immunology space | Président | 01/04/2016 |
IDEA AG
 IDEA AG Pharmaceuticals: MajorHealth Technology Develops pain therapeutics and biopharmaceutical drugs | Directeur/Membre du Conseil | 01/11/2021 |
Efficas Medical Foods & Nutrition LLC
 Efficas Medical Foods & Nutrition LLC BiotechnologyHealth Technology Develops science-based consumer products for the nutritional management of the immune system for both humans and pets | Directeur/Membre du Conseil | 11/05/2010 |
Anciens postes connus de Jörg Neermann
| Sociétés | Poste | Fin |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Directeur/Membre du Conseil | 21/06/2023 |
Curexsys GmbH
 Curexsys GmbH Miscellaneous Commercial ServicesCommercial Services Provides scientific research and development services | Directeur Général | 01/01/2022 |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Directeur/Membre du Conseil | 01/01/2021 |
ViCentra BV
 ViCentra BV Medical SpecialtiesHealth Technology Manufactures insulin pumps | Directeur/Membre du Conseil | 01/01/2021 |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jörg Neermann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
34
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 34 |
|---|---|
Deutsche Bank AG
 Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services | Finance |
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
NextGen Group Plc
 NextGen Group Plc Miscellaneous Commercial ServicesCommercial Services Provides biomarker services for pharmaceutical and biotech companies globally | Commercial Services |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Finance |
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals | Health Technology |
DVC Deutsche Venture Capital
 DVC Deutsche Venture Capital Investment ManagersFinance DVC is a venture capital investment manager focused on European high-growth, early-stage companies with global expansion potential. The firm invests in sectors including life sciences, information technology, telecommunication, semiconductor and industrial technologies. In the field of life sciences, DVC invests specifically in the development of therapeutic products, diagnostics, medical devices and biotechnology platforms. Their technology investments target businesses whose activity pertains to 1) the management of information, applications and infrastructure, 2) communication applications and platforms as well as network infrastructure, and 3) technologies related to optics, automation, sensors, electronics, semiconductors and materials. DVC aims to leverage their access to Deutsche Bank's international network and lead their portfolio companies from technological leadership to international market success. Investment criteria include distinctive technology with adequate IP protection and addressing a clearly identified market, an experienced management team and leadership potential in high-growth markets internationally. The firm is generally the lead investor in German-speaking countries, and co-leads in other European countries and the US. They aim to keep their portfolio balanced across their target sectors and across development stages, with a majority of early-stage investments complemented with expansion-phase investments with short-term exit potential. DVC actively assists their portfolio companies with financial issues, key hires and marketing strategy without interfering in operational management. | Finance |
Kuros Biosurgery Holding AG
 Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs for biosurgery, tissue repair and regeneration | Commercial Services |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
IDEA AG
IDEA AG Pharmaceuticals: MajorHealth Technology Develops pain therapeutics and biopharmaceutical drugs | Health Technology |
Avontec GmbH
 Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Health Technology |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Retail Trade |
Efficas Medical Foods & Nutrition LLC
Efficas Medical Foods & Nutrition LLC BiotechnologyHealth Technology Develops science-based consumer products for the nutritional management of the immune system for both humans and pets | Health Technology |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
NextGen Sciences Ltd.
 NextGen Sciences Ltd. BiotechnologyHealth Technology Provides technologies and reagents for molecular biology and protein research | Health Technology |
Technische Universität Braunschweig
 Technische Universität Braunschweig Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KeyNeurotek Pharmaceuticals AG
 KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology Develops small molecule drugs for the treatment of neuronal and autoimmune diseases | Health Technology |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Vivendy Therapeutics Ltd.
 Vivendy Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Develops enzyme replacement therapy and biological products | Health Services |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Develops miniaturized and integrated molecular diagnostic solutions | Health Technology |
Vectura GmbH
 Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
LSP Services Deutschland GmbH
 LSP Services Deutschland GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
EyeSense AG
 EyeSense AG Medical SpecialtiesHealth Technology Develops and manufactures continuous blood glucose monitoring systems for diabetes patients | Health Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ViCentra BV
ViCentra BV Medical SpecialtiesHealth Technology Manufactures insulin pumps | Health Technology |
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Health Technology |
Affimed AG | |
Kuros Biosciences Ltd.
 Kuros Biosciences Ltd. BiotechnologyHealth Technology Develops biological products for tissue repair | Health Technology |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals in the immunology space | Health Technology |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Curexsys GmbH
Curexsys GmbH Miscellaneous Commercial ServicesCommercial Services Provides scientific research and development services | Commercial Services |
